TABLE 2.
Number of measurements and positive humoral and T cell-mediated responses by organ transplant group (liver of lung) and time from COVID-19 vaccine doses.
Transplanted organ | Time | No. of antibody measurements | No. of T cell- mediated response measurements | Positive antibody responses (% of total measurements) | Positive T cell-mediated responses (% of total measurements) |
---|---|---|---|---|---|
Liver | 60 days post 2nd dose | 222 | 54 | 190 (85.6) | 41 (75.9) |
60 days post 3rd dose | 238 | 95 | 226 (95.0) | 90 (94.7) | |
Lung | 60 days post 2nd dose | 93 | 83 | 67 (72.0) | 57 (68.7) |
60 days post 3rd dose | 83 | 72 | 72 (86.7) | 62 (86.1) |